Springvest

Springvest is a crowdfunding platform based in Helsinki, Finland, established in 2012. It aims to streamline the financing process for promising Finnish growth companies, allowing them to focus on their business rather than spending excessive time on fundraising. By connecting these companies with investors seeking higher potential opportunities, Springvest facilitates financing rounds that empower businesses to capitalize on their ideas more quickly and effectively. The platform encourages Finnish investors to engage with local growth companies, fostering a community that supports innovation and potential success in the Finnish market.

Jouni Mäkelä

Investment Director

19 past transactions

Volare

Series A in 2024
Volare is a food technology company focused on upcycling industrial food waste into sustainable protein, oil, and fertilizer ingredients. The company utilizes black soldier flies and proprietary technology to transform food waste into high-quality protein and lipid products. By providing sustainable alternatives to environmentally damaging ingredients such as fishmeal, soy, and palm oil, Volare aims to support food manufacturers and processors in achieving their sustainability targets. The company's mission is to reduce the environmental burden of the food chain while aiding large food corporations in meeting their climate and nature goals.

Solar Foods

Series B in 2024
Solar Foods Ltd. is a food-tech startup based in Lappeenranta, Finland, founded in 2017. The company specializes in producing a sustainable protein called Solein, which serves as an alternative to animal-derived proteins. Solein is developed through a unique process that combines electricity, hydrogen, carbon dioxide, water, vitamins, and minerals to cultivate microbial biomass. This method utilizes gas fermentation, allowing the production of edible calories from hydrogen-oxidizing microbes without reliance on traditional agriculture, weather, or climate conditions. Solar Foods aims to provide nutritious food ingredients and plant-based meat alternatives that promote sustainability in food production.

Desentum

Venture Round in 2024
Desentum is a research-oriented biopharmaceutical company specialized in developing novel types of allergy vaccines that are based on switching the immune system's response to allergens from hypersensitivity to tolerance. They have a unique approach for designing allergy vaccines. By studying the molecular mechanism of the hypersensitivity reaction, they have made discoveries that allow for improved design of vaccines against common types of allergies. Their goal is to provide long-term relief for patients suffering from allergic symptoms, as well as reduce the social and economic burden allergies cause to both individuals and society.

Solar Foods

Series B in 2023
Solar Foods Ltd. is a food-tech startup based in Lappeenranta, Finland, founded in 2017. The company specializes in producing a sustainable protein called Solein, which serves as an alternative to animal-derived proteins. Solein is developed through a unique process that combines electricity, hydrogen, carbon dioxide, water, vitamins, and minerals to cultivate microbial biomass. This method utilizes gas fermentation, allowing the production of edible calories from hydrogen-oxidizing microbes without reliance on traditional agriculture, weather, or climate conditions. Solar Foods aims to provide nutritious food ingredients and plant-based meat alternatives that promote sustainability in food production.

Kuva Space

Series A in 2023
Kuva Space utilizes a constellation of nanosatellites equipped with hyperspectral imaging technology to provide critical data for managing natural resources and promoting sustainable economic growth. The company's GREEN DATA® platform leverages artificial intelligence to offer actionable insights that address significant global challenges such as climate change, disaster response, food demand, and safety. By enabling clients to monitor agricultural productivity, optimize land use, and make informed investment decisions, Kuva Space facilitates regional carbon sequestration measurement, aids in forest fire prevention, and detects gas leaks. Overall, Kuva Space aims to enhance life on Earth through advanced satellite technology and data-driven solutions.

MedicubeX

Seed Round in 2023
MedicubeX is focused on transforming preventive healthcare through the development of autonomous self-measurement and telehealth eHealth Stations. As the most advanced health kiosk in the Nordics, MedicubeX provides regular clinical-grade medical check-ups accessible to individuals regardless of their location. The eHealth Station is designed to measure vital signs and assess risk factors, particularly for cardiovascular diseases, within a few minutes. It operates autonomously, featuring automated disinfection for umbilical venous catheters and ensuring privacy for optional remote consultations. This innovative approach enables users to monitor their health status efficiently and supports scalable solutions for preventive healthcare.

Cerenion

Series A in 2022
Cerenion is a medical device company dedicated to improving the care of patients suffering from brain injuries due to medical emergencies such as strokes, cardiac arrests, and epileptic seizures. The company has developed C-Trend, a patented technology that utilizes artificial intelligence to provide rapid and reliable brain monitoring in hospital emergency and intensive care units. By enabling electroencephalography (EEG) monitoring within minutes, C-Trend enhances patient diagnostics and treatment while also aiming to reduce healthcare costs. The technology simplifies complex EEG data into accessible parameters, facilitating clinical decision-making for medical professionals and ultimately improving patient outcomes in critical care settings.

Desentum

Venture Round in 2022
Desentum is a research-oriented biopharmaceutical company specialized in developing novel types of allergy vaccines that are based on switching the immune system's response to allergens from hypersensitivity to tolerance. They have a unique approach for designing allergy vaccines. By studying the molecular mechanism of the hypersensitivity reaction, they have made discoveries that allow for improved design of vaccines against common types of allergies. Their goal is to provide long-term relief for patients suffering from allergic symptoms, as well as reduce the social and economic burden allergies cause to both individuals and society.

Rocsole

Series A in 2021
Rocsole is a technology company specializing in tomographic process monitoring for various industrial applications, including the oil and gas sector, food, chemicals, and pulp and paper industries. Founded in 2012 and headquartered in Houston, Texas, Rocsole develops sensors that employ electrical capacitance tomography to generate real-time 3D images of multiphase flows. Its product offerings include solutions for monitoring emulsions, deposition, and sand, along with specialized applications like measuring entrained air and detecting soap interfaces. The company also provides a range of services, such as process optimization, piloting, and electronics design. Rocsole's innovative approach incorporates artificial intelligence and deep learning to deliver actionable insights, helping clients reduce operational costs and enhance energy efficiency.

Bioretec

Private Equity Round in 2021
Bioretec Ltd. is a Finnish company specializing in the development, manufacturing, and marketing of bioabsorbable and bioactive surgical implants. These implants are designed for use in orthopedic, trauma, and sports medicine surgeries, catering to both pediatric and adult patients. Bioretec's products, recognized for their safety and reliability, are utilized globally and are engineered for high-load-bearing clinical applications. The company continues to innovate in material technology, with notable brands including RemeOs, Activa IM-N, ActivaPi, and ActivaScrew.

Verto Analytics

Series C in 2019
Verto Analytics Inc. specializes in audience cross-platform measurement solutions, focusing on consumer behavior across various devices, applications, and platforms. The company operates a passive metering panel that captures a comprehensive range of digital interactions, allowing researchers, advertisers, and publishers to analyze media consumption trends effectively. Verto offers several products, including Verto App Watch, which tracks user engagement and demographics for mobile applications, and Verto Content Watch, which helps publishers and marketers assess audience reach and competition. Additional offerings such as Verto Index and Verto Retention Reports provide insights into user adoption, loyalty, and engagement metrics. By delivering detailed data on consumer behaviors and preferences, Verto Analytics enables clients to optimize their marketing strategies and understand market dynamics. Established in 2013, Verto Analytics is headquartered in New York City, with additional offices in San Francisco, London, and Helsinki.

Convion

Series A in 2018
Convion Ltd. is a Finnish company, established in 2012 and located in Espoo, that specializes in the development and manufacturing of solid oxide fuel cells for power generation. The company focuses on creating high-efficiency systems that facilitate distributed power generation and hydrogen production, utilizing various fuels to enhance energy independence and security. Convion's modular fuel cell systems are designed for industrial and commercial applications, offering operational flexibility and reliability. By leveraging solid oxide fuel cell technology, Convion aims to contribute to sustainable energy solutions and improve the efficiency of power generation markets.

Mobidiag

Venture Round in 2018
Mobidiag is a Finnish-French biotechnology company that focuses on developing and marketing innovative molecular diagnostic solutions aimed at detecting gastrointestinal infections, antimicrobial resistance, healthcare-associated infections, respiratory infections, and sepsis. Utilizing established qPCR and microarray technologies, Mobidiag provides a wide array of fast, reliable, and cost-effective diagnostic tests and automated platforms suitable for laboratories of various sizes. Their offerings enable the detection of a broad spectrum of clinically relevant bacteria, parasites, viruses, and antibiotic resistance markers, thereby facilitating quicker diagnosis and treatment in hospitals, laboratories, and clinics.

Finbiosoft

Series A in 2018
Finbiosoft is a company focused in developing Validation Manager™ software service. Validation Manager is the perfect tool for clinical laboratories and diagnostic companies to digitalize, automate and standardize the time-consuming and error sensitive data handling of validations and verifications.

Ductor

Series A in 2017
Ductor is a Finnish biotechnology company specializing in the sustainable production of ammonia and phosphates from recycled materials. The company has developed proprietary technology that can be integrated into various applications, including algae farming, to provide essential nutrients and renewable energy. Ductor aims to address critical challenges such as climate change, increasing food demand, and waste accumulation by offering organic fertilizers and renewable energy derived from biogas. The company has recently achieved a strategic milestone by commencing industrial-scale production, with its first implementation set to enhance the economics of existing biogas production facilities. This innovative approach supports farmers and food producers in maintaining healthy soils and adopting ecological farming practices.

Desentum

Series A in 2017
Desentum is a research-oriented biopharmaceutical company specialized in developing novel types of allergy vaccines that are based on switching the immune system's response to allergens from hypersensitivity to tolerance. They have a unique approach for designing allergy vaccines. By studying the molecular mechanism of the hypersensitivity reaction, they have made discoveries that allow for improved design of vaccines against common types of allergies. Their goal is to provide long-term relief for patients suffering from allergic symptoms, as well as reduce the social and economic burden allergies cause to both individuals and society.

ArcDia

Series A in 2017
The mariPOC® test system allows a multi-analytical result from one patient sample with one analysis. The test system provides central laboratory-level accuracy for patient-centered diagnostics. The reliability of the results is verified by automatic testing of the test system.

Ukkoverkot

Series A in 2017
Ukkoverkot Ltd is a Finnish mobile data operator that specializes in the maintenance, sale, and marketing of a 450 MHz 4G LTE mobile data network, which provides nationwide coverage across Finland. The company is dedicated to delivering wireless telecommunication services tailored for businesses, authorities, and other demanding user groups, and does not provide voice or SMS services. In addition to its comprehensive national network, Ukkoverkot offers high-speed mobile network solutions designed to meet both continuous and temporary connectivity needs in specific areas.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.